Benchmark Maintains Buy on Enovix, Lowers Price Target to $15

Benzinga Newsdesk www.benzinga.com Negative 78.8%

Neg 78.8% Neu 0% Pos 0%

Benchmark analyst Mickey Legg maintains Enovix (NASDAQ:ENVX) with a Buy and lowers the price target from $25 to $15.

Comments

No comments yet. Be the first!